FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of general formula:
or its pharmaceutically acceptable salt wherein the ring A represents a phenyl group which can contain 1-3 substitutes specified in a group of substitutes, or a thienyl group which can contain 1-3 substitutes specified in a group of substitutes α; L represents a single bond or a group of formula -NRC CO- (wherein Re represents a hydrogen atom), the ring B represents C6-14 aryl group which can contain 1-3 substitutes specified in a group of substitutes α, or a 5-10-member heterocyclic group which can contain 1-3 substitutes specified in a group of substitutes α; the X, Y, Z , R1 and R2 , R3, R4, R5 and R6 radical values are presented in cl.1 of the patent claim which possess an effect of Aβ protein production inhibition or an effect of BACE1 inhibition.
EFFECT: preparing the compound which is applicable as a preventive or therapeutic agent for neurodegenerative disease caused by Aβ.
13 cl, 35 tbl, 285 ex
Title | Year | Author | Number |
---|---|---|---|
CONDENSED AMINODIHYDROTHIAZINE DERIVATIVES APPLICABLE AS BACE INHIBITORS | 2012 |
|
RU2593756C2 |
CYNNAMIDE COMPOUND | 2005 |
|
RU2361872C2 |
NEW PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (1) | 2005 |
|
RU2330021C2 |
PROTEIN KINASE INHIBITORS FOR ENHANCING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | 2019 |
|
RU2822216C2 |
1,2,4-TRIAZOLONE DERIVATIVE | 2011 |
|
RU2566754C2 |
PYRAZOLE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT | 2016 |
|
RU2687245C1 |
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
NOVEL PYRIDINE DERIVATIVE AND DERIVATIVE OF PYRIMIDINE (3) | 2006 |
|
RU2362771C1 |
NEW OCTAHYDROTHIENOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING DERIVATIVE, AND USING THEM | 2012 |
|
RU2573399C2 |
NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION BASED THEREON, USE THEREOF AND METHOD OF TREATING AND/OR PREVENTING DISEASE | 2009 |
|
RU2474575C2 |
Authors
Dates
2013-02-27—Published
2009-01-16—Filed